Imlygic 10e6
As listed in the register: Imlygic 10e6, Injektionslösung
·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Talimogenum laherparepvecum
- Made by
- Amgen Switzerland AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Imlygic ist zur Behandlung von Melanomen mit regionalen oder entfernten Metastasen bei Erwachsenen indiziert.
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Amgen Switzerland AG |
|---|---|
| Active substance | Talimogenum laherparepvecum |
| Used in | Cancer treatments and immune-system medicines |
| Classification | L01XL02 · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Imlygic 10e6, Injektionslösung |
| Packs | 1 ml Durchstechflasche(n) |
| Zulassungsnummer | 65812 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.